Age-related decrease of miRNA-92a levels in human CD8⁺T-cells correlates with a reduction of naïve T lymphocytes

Por Ohyashiki Michiyo, Ohyashiki Junko H, Hirota Ayako, Kobayashi Chiaki, Ohyashiki Kazuma
Publicado em 2011-11-01

A network biology approach evaluating the anticancer effects of bortezomib identifies SPARC as a therapeutic target in adult T-cell leukemia cells

Por Ohyashiki, Junko H, Hamamura, Ryoko, Kobayashi, Chiaki, Zhang, Yu, Ohyashiki, Kazuma
Publicado em 2008

Age-related decrease of miRNA-92a levels in human CD8(+ )T-cells correlates with a reduction of naïve T lymphocytes

Por Ohyashiki, Michiyo, Ohyashiki, Junko H, Hirota, Ayako, Kobayashi, Chiaki, Ohyashiki, Kazuma
Publicado em 2011

Exosomes Derived from Hypoxic Leukemia Cells Enhance Tube Formation in Endothelial Cells

Por Tadokoro, Hiroko, Umezu, Tomohiro, Ohyashiki, Kazuma, Hirano, Toshihiko, Ohyashiki, Junko H.
Publicado em 2013

The C allele of JAK2 rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population

Por Ohyashiki, Junko H, Yoneta, Masayuki, Hisatomi, Hisashi, Iwabuchi, Tamiko, Umezu, Tomohiro, Ohyashiki, Kazuma
Publicado em 2012

Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1

Por Umezu, Tomohiro, Tadokoro, Hiroko, Azuma, Kenko, Yoshizawa, Seiichiro, Ohyashiki, Kazuma, Ohyashiki, Junko H.
Publicado no Blood (2014)

Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR-92a

Por Ohyashiki, Junko H, Umezu, Tomohiro, Kobayashi, Chiaki, Hamamura, Ryoko S, Tanaka, Masami, Kuroda, Masahiko, Ohyashiki, Kazuma
Publicado em 2010

Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: a possible biomarker to discontinue imatinib safel...

Por Ohyashiki, Junko H, Ohtsuki, Kazushige, Mizoguchi, Izuru, Yoshimoto, Takayuki, Katagiri, Seiichiro, Umezu, Tomohiro, Ohyashiki, Kazuma
Publicado em 2014

Expression Profile of a γ-Deletion Variant of the Human Telomerase Reverse Transcriptase Gene

Por Hisatomi, Hisashi, Ohyashiki, Kazuma, Ohyashiki, Junko H, Nagao, Kumi, Kanamaru, Taichi, Hirata, Hiroyuki, Hibi, Nozomu, Tsukada, Yutaka
Publicado em 2003

Downregulation of Plasma miR-215 in Chronic Myeloid Leukemia Patients with Successful Discontinuation of Imatinib

Por Ohyashiki, Kazuma, Umezu, Tomohiro, Katagiri, Seiichiro, Kobayashi, Chiaki, Azuma, Kenko, Tauchi, Tetsuzo, Okabe, Seiichi, Fukuoka, Yutaka, Ohyashiki, Junko H.
Publicado no Int J Mol Sci (2016)

Clinical Impact of Down-Regulated Plasma miR-92a Levels in Non-Hodgkin's Lymphoma

Por Ohyashiki, Kazuma, Umezu, Tomohiro, Yoshizawa, Sei-ichiro, Ito, Yoshikazu, Ohyashiki, Michiyo, Kawashima, Hisashi, Tanaka, Masami, Kuroda, Masahiko, Ohyashiki, Junko H.
Publicado em 2011

Immunosurveillance markers may predict patients who can discontinue imatinib therapy without relapse

Por Yoshimoto, Takayuki, Mizoguchi, Izuru, Katagiri, Seiichiro, Tauchi, Tetsuzo, Furusawa, Jun-ichi, Chiba, Yukino, Mizuguchi, Junichiro, Ohyashiki, Junko H, Ohyashiki, Kazuma
Publicado em 2014